1. Home
  2. MOLN vs SMHI Comparison

MOLN vs SMHI Comparison

Compare MOLN & SMHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOLN
  • SMHI
  • Stock Information
  • Founded
  • MOLN 2004
  • SMHI 1989
  • Country
  • MOLN Switzerland
  • SMHI United States
  • Employees
  • MOLN N/A
  • SMHI N/A
  • Industry
  • MOLN
  • SMHI Marine Transportation
  • Sector
  • MOLN
  • SMHI Consumer Discretionary
  • Exchange
  • MOLN Nasdaq
  • SMHI Nasdaq
  • Market Cap
  • MOLN 136.1M
  • SMHI 139.9M
  • IPO Year
  • MOLN 2021
  • SMHI N/A
  • Fundamental
  • Price
  • MOLN $3.71
  • SMHI $5.20
  • Analyst Decision
  • MOLN
  • SMHI
  • Analyst Count
  • MOLN 0
  • SMHI 0
  • Target Price
  • MOLN N/A
  • SMHI N/A
  • AVG Volume (30 Days)
  • MOLN 2.4K
  • SMHI 122.6K
  • Earning Date
  • MOLN 08-25-2025
  • SMHI 07-30-2025
  • Dividend Yield
  • MOLN N/A
  • SMHI N/A
  • EPS Growth
  • MOLN N/A
  • SMHI N/A
  • EPS
  • MOLN N/A
  • SMHI N/A
  • Revenue
  • MOLN $2,525,030.00
  • SMHI $264,089,999.00
  • Revenue This Year
  • MOLN N/A
  • SMHI N/A
  • Revenue Next Year
  • MOLN $866.67
  • SMHI $11.59
  • P/E Ratio
  • MOLN N/A
  • SMHI N/A
  • Revenue Growth
  • MOLN N/A
  • SMHI N/A
  • 52 Week Low
  • MOLN $3.36
  • SMHI $3.63
  • 52 Week High
  • MOLN $12.22
  • SMHI $15.36
  • Technical
  • Relative Strength Index (RSI)
  • MOLN 51.23
  • SMHI 40.64
  • Support Level
  • MOLN $3.58
  • SMHI $5.00
  • Resistance Level
  • MOLN $3.86
  • SMHI $5.42
  • Average True Range (ATR)
  • MOLN 0.16
  • SMHI 0.29
  • MACD
  • MOLN 0.01
  • SMHI -0.11
  • Stochastic Oscillator
  • MOLN 50.79
  • SMHI 5.56

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About SMHI SEACOR Marine Holdings Inc.

Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.

Share on Social Networks: